{
    "clinical_study": {
        "@rank": "117880", 
        "brief_summary": {
            "textblock": "To study the effectiveness of alpha interferon (IFN-A2b) and zidovudine (AZT) in treating\n      progressive multifocal leukoencephalopathy (PML) as a complication of HIV-1 infection."
        }, 
        "brief_title": "A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection", 
        "condition": [
            "HIV Infections", 
            "Leukoencephalopathy, Progressive Multifocal"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Leukoencephalopathy, Progressive Multifocal", 
                "Leukoencephalopathies"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients must have:\n\n          -  HIV seropositivity by both ELISA and Western blot.\n\n          -  Biopsy proven progressive multifocal leukoencephalopathy (PML).\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following conditions or symptoms are excluded:\n\n          -  Intolerant to interferon.\n\n          -  Prior or concomitant central nervous system disease (CNS) such as toxoplasmosis,\n             multiple sclerosis (MS), or neurosyphilis.\n\n        Patients with the following are excluded:\n\n          -  Intolerant to interferon.\n\n          -  Prior or concomitant central nervous system disease (CNS) such as toxoplasmosis,\n             multiple sclerosis (MS), or neurosyphilis.\n\n        Prior Medication:\n\n        Excluded:\n\n          -  Patients receiving interferon for other reasons."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002270", 
            "org_study_id": "074A"
        }, 
        "intervention": [
            {
                "intervention_name": "Interferon alfa-2b", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Zidovudine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Interferon-alpha", 
                "Interferon Alfa-2a", 
                "Interferon Alfa-2b", 
                "Interferons", 
                "Zidovudine", 
                "Reaferon"
            ]
        }, 
        "keyword": [
            "Leukoencephalopathy, Progressive Multifocal", 
            "Interferon Alfa-2b", 
            "Drug Evaluation", 
            "Acquired Immunodeficiency Syndrome", 
            "Zidovudine"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Miami", 
                    "country": "United States", 
                    "state": "Florida", 
                    "zip": "33136"
                }, 
                "name": "Univ of Miami School of Medicine"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002270"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Miami", 
                "agency_class": "Other"
            }
        }, 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 1991"
    }, 
    "geocoordinates": {
        "Univ of Miami School of Medicine": "25.789 -80.226"
    }
}